The Compounding Pharmacy of Beverly Hills, Beverly Hills, CA

Is The Compounding Pharmacy of Beverly Hills registered with the FDA as a 503B outsourcing facility?

No matching record found in FDA’s registered outsourcing facility list (updated Nov 6, 2026) on Nov 15, 2026, searching by name and location. FDA’s compounding inspections and actions page labels it a 503A facility.

Does The Compounding Pharmacy of Beverly Hills hold a California pharmacy license?

The California State Board of Pharmacy lists license PHY 57735 for The Compounding Pharmacy Of Beverly Hills, Beverly Hills, status Active, as of Nov 6, 2026.

Has The Compounding Pharmacy of Beverly Hills had a state board action or FDA letter?

FDA letters: record found. FDA’s compounding inspections and actions page, current as of Oct 22, 2026, lists 1 untitled letter (Sep 17, 2020) and 1 FMD-145 letter (Jan 13, 2021) for The Compounding Pharmacy of Beverly Hills. State board actions: no California State Board of Pharmacy action on license PHY 57735 or under this exact name and city was found in the board’s posted disciplinary decisions on facility licenses (actions dated Jan 5, 2005 to Oct 28, 2026) on Nov 6, 2026.

FDA registers 503B outsourcing facilities; state boards of pharmacy license pharmacies, including 503A compounding pharmacies, and keep their own disciplinary records. Neither FDA list says which drugs a pharmacy makes.

Names in FDA records
The Compounding Pharmacy of Beverly Hills
Location
Beverly Hills, CA
Type as FDA labels it
503A
FDA 503B list
No matching record found
Form 483s on FDA’s actions page
1
Warning letters on FDA’s actions page
0
Latest action on that page
Jan 13, 2021
FDA Data Dashboard inspections
No matching site found
State board records
License found: PHY 57735, Active

FDA inspections and letters

FDA’s compounding inspections and actions page (current as of Oct 22, 2026) lists this pharmacy as The Compounding Pharmacy of Beverly Hills, a 503A facility, with 3 dated actions.

Document
Jan 13, 2021FMD-145 letterFMD-145 Letter Issued 01/13/2021FDA copy (archived)
Sep 17, 2020Untitled letterUntitled Letter Issued 09/17/2020FDA copy (archived)
Aug 16, 2019Form 483483 Issued 08/16/2019Not linked by FDA

A Form 483 lists investigator observations, not a final FDA determination. An untitled or FMD-145 letter states FDA’s view when it was issued.

FDA inspection classifications and published Form 483s

No inspected site under this exact name and city was found in the FDA Data Dashboard on Nov 15, 2026, searching 12,593 US sites with a drug inspection ending Oct 1, 2008 to Oct 23, 2026. FDA may list the site under another legal name, so this is not a finding that it was never inspected.

State board of pharmacy records

The California State Board of Pharmacy file dated Nov 6, 2026 lists these licenses under the same name, city and state as this pharmacy. Board file.

LicenseType as the board gives itName on the board recordCityStatus
PHY 57735Retail PharmacyThe Compounding Pharmacy Of Beverly HillsBeverly HillsActive

What this covers: Facility license decisions from the board’s quarterly Disciplinary Actions pages (87 of 88 quarters had a facility section). These are final decisions; accusations filed and immediate protection orders are not included. Actions in the data are dated Jan 5, 2005 to Oct 28, 2026.

This page restates FDA’s lists and state board of pharmacy records. A Form 483, letter or board action is not a finding by this site, and a missing record is not a finding either way. A state license is matched only on the same name, city and state. Follow each link for the original document. Report an error or add a company response.

Sources

Records last pulled Nov 15, 2026. Every entry links to the original public record.